These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38592657)

  • 21. Valuing the EQ Health and Wellbeing Short Using Time Trade-Off and a Discrete Choice Experiment: A Feasibility Study.
    Mukuria C; Peasgood T; McDool E; Norman R; Rowen D; Brazier J
    Value Health; 2023 Jul; 26(7):1073-1084. PubMed ID: 36805577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe.
    Golicki D; Jakubczyk M; Graczyk K; Niewada M
    Pharmacoeconomics; 2019 Sep; 37(9):1165-1176. PubMed ID: 31161586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. United States Valuation of EQ-5D-5L Health States Using an International Protocol.
    Pickard AS; Law EH; Jiang R; Pullenayegum E; Shaw JW; Xie F; Oppe M; Boye KS; Chapman RH; Gong CL; Balch A; Busschbach JJV
    Value Health; 2019 Aug; 22(8):931-941. PubMed ID: 31426935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study Protocol.
    Rowen D; Mukuria C; Bray N; Carlton J; Cooper S; Longworth L; Meads D; O'Neill C; Yang Y
    Value Health; 2023 Nov; 26(11):1625-1635. PubMed ID: 37722593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How Prevalent Are Implausible EQ-5D-5L Health States and How Do They Affect Valuation? A Study Combining Quantitative and Qualitative Evidence.
    Yang Z; Feng Z; Busschbach J; Stolk E; Luo N
    Value Health; 2019 Jul; 22(7):829-836. PubMed ID: 31277831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
    Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
    Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off.
    Jiang R; Shaw J; Mühlbacher A; Lee TA; Walton S; Kohlmann T; Norman R; Pickard AS
    Qual Life Res; 2021 May; 30(5):1433-1444. PubMed ID: 33247810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.
    Longworth L; Yang Y; Young T; Mulhern B; Hernández Alava M; Mukuria C; Rowen D; Tosh J; Tsuchiya A; Evans P; Devianee Keetharuth A; Brazier J
    Health Technol Assess; 2014 Feb; 18(9):1-224. PubMed ID: 24524660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The EQ-5D-5L Valuation study in Thailand.
    Pattanaphesaj J; Thavorncharoensap M; Ramos-Goñi JM; Tongsiri S; Ingsrisawang L; Teerawattananon Y
    Expert Rev Pharmacoecon Outcomes Res; 2018 Oct; 18(5):551-558. PubMed ID: 29958008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach.
    Ramos-Goñi JM; Craig BM; Oppe M; Ramallo-Fariña Y; Pinto-Prades JL; Luo N; Rivero-Arias O
    Value Health; 2018 May; 21(5):596-604. PubMed ID: 29753358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments.
    Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV
    Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.
    Feng Y; Herdman M; van Nooten F; Cleeland C; Parkin D; Ikeda S; Igarashi A; Devlin NJ
    Qual Life Res; 2017 Aug; 26(8):2067-2078. PubMed ID: 28343350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the importance of controlling heteroskedasticity and heterogeneity in health valuation: a case study on Dutch EQ-5D-5L.
    Karim S; Craig BM; Groothuis-Oudshoorn CGM
    Health Qual Life Outcomes; 2022 May; 20(1):85. PubMed ID: 35614472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol.
    Hansen TM; Helland Y; Augestad LA; Rand K; Stavem K; Garratt A
    BMJ Open; 2020 Jun; 10(6):e034683. PubMed ID: 32532768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preference heterogeneity in health valuation: a latent class analysis of the Peru EQ-5D-5L values.
    Karim S; Craig BM; Tejada RA; Augustovski F
    Health Qual Life Outcomes; 2023 Jan; 21(1):1. PubMed ID: 36593473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Being a quantitative interviewer: qualitatively exploring interviewers' experiences in a longitudinal cohort study.
    Derrett S; Colhoun S
    BMC Med Res Methodol; 2011 Dec; 11():165. PubMed ID: 22165989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.
    Stolk E; Ludwig K; Rand K; van Hout B; Ramos-Goñi JM
    Value Health; 2019 Jan; 22(1):23-30. PubMed ID: 30661630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults.
    Ferreira LN; Ferreira PL; Ribeiro FP; Pereira LN
    Health Qual Life Outcomes; 2016 Jun; 14():89. PubMed ID: 27267761
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.